SCHEMBL8562993

SCHEMBL8562993

CCCc1nc(C(C)C)c(C(=O)OCC)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HTT P42858 2/20 0.43
RECQL P46063 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 1/20 0.37
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371738 0.90 CYP1A2 (0.44) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL11325666 0.88 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL27836922 0.87 ALDH1A1 (0.40) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL2472768 0.86 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL7300673 0.82 CYP1A2 (0.42) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL20295385 0.81 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL5809049 0.81 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL27352613 0.81 GLA (0.34) ALDH1A1KDM4EPOLBKMT2AMAPK1
SCHEMBL1275935 0.80 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EHTTRECQL
SCHEMBL11049418 0.80 GLA (0.33) ALDH1A1CYP1A2CYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020043025-A1 HYDRATE OF 4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYLIMIDAZOLE-5-CARBOXYLIC ACID ETHYL ESTER 黄冈鲁班药业股份有限公司 2020-03-05 WO disclosed
EP-0603001-B1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO CO (JP) 1998-08-26 EP disclosed
US-5459148-A Cardiovascular disorders SANKYO COMPANY, LIMITED (JP) 1995-10-17 US disclosed
EP-0603001-A1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO COMPANY LIMITED (JP) 1994-06-22 EP disclosed